Navigation Links
GenWay Biotech's You Test You puts early cancer detection tool in the hands of consumers
Date:3/1/2010

San Diego-based GenWay Biotech, Inc. today announced the availability of the You Test You Cancer Assessment that allows patients to test for various types of cancer without having to visit their doctor's office, through a simple blood sample. With a 10-day turnaround time and a cost of $149, You Test You is a convenient and low cost way to periodically test for indication of cancer.

The test can be ordered online through the www.youtestyou.com Web site. The patient completes an online form, which is reviewed by a You Test You doctor. Upon approval, the patient visits a local laboratory to have a blood sample taken. You Test You is an easily accessible and effective method for detecting evidence of cancer, which may lead to diagnosing and treating cancer earlier. Diagnosing cancer in the early stages can lead to successful treatment and an increased survival rate.

"The American Cancer Society has stressed the importance of early cancer detection, yet for various reasons, many Americans do not have regular checkups with their doctors", said GenWay CEO Robert Gans. "This convenient and inexpensive test will provide a valuable means for patients to be proactive and evaluate certain proteins found in the blood which are frequently associated with most cancers"

George Delgado, M.D., specialist in family medicine and voluntary associate clinical professor at UC San Diego says, "The You Test You Cancer Assessment is a great test for people who want to take charge of their health and make better health decisions."

The launch of You Test You is particularly timely, given recent recommendations from various sources setting guidelines for both breast and cervical cancer screening. The test is the first of its kind for cancer, helping patients monitor their own health. In addition to the lab-based test, a home sample collection kit will be available early this year.

According to Sergey Sikora, GenWay's Vice President of Business Development, "You Test You is a step toward putting health care into the hands of patients, many of whom do not have the time or money for expensive cancer testing. We are proud to offer a test that, with a prescription from our doctor, is widely accessible to the general consumer."


'/>"/>

Contact: Jill Dombrauckas
jdom@genwaybio.com
858-458-0866 x119
GenWay Biotech
Source:Eurekalert

Related biology news :

1. GenWay Biotech obtains exclusive rights to AMDLs DR-70 cancer test in US and Canada
2. General tumor marker test now offered by GenWay clinical laboratory
3. GenWay Clinical Laboratory receives accreditation from College of American Pathologists
4. 60 second test could help early diagnosis of common brain diseases
5. Restless legs syndrome affects nearly 2 percent of US/UK children
6. Bleeding, not inflammation, is major cause of early lung infection death
7. Pig study sheds new light on the colonisation of Europe by early farmers
8. Color contrast is seen by the brain early doors
9. Extra gene copies were enough to make early humans mouths water
10. Was ability to run early mans Achilles heel?
11. New technique can be breakthrough for early cancer diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
(Date:2/8/2017)... -- Report Highlights The global biosurgery market ... in 2016 at a compound annual growth rate (CAGR) ... - An overview of the global market for biosurgery. ... 2015 and 2016, and projections of compound annual growth ... on the basis of product type, source, application, and ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... Corporation (NASDAQ: VWR), the leading global independent provider of product ... its financial results for the fourth quarter and full year ... 4Q16 record quarterly net sales of $1.13 billion, up ... 4Q16 EMEA-APAC segment net sales increased ... net sales increased 2.5%, or down 0.9% on an organic ...
(Date:2/23/2017)... Feb. 23, 2017 /PRNewswire/ - The Fight Against Cancer ... Research (OICR) are pleased to report that Fusion Pharmaceuticals ... with Johnson & Johnson Innovation – JJDC, Inc. (JJDC) ... groups HealthCap, TPG Biotechnology Partners, and Genesys Capital, as ... ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... de novo clearance to begin marketing the SPEAC® System, the Brain Sentinel® Seizure ... at home or in healthcare facilities during periods of rest. A lightweight, non-invasive ...
Breaking Biology Technology: